Literature DB >> 21331299

POTENTIAL APPLICATION OF GRAPE DERIVED POLYPHENOLS IN HUNTINGTON'S DISEASE.

Jun Wang1, Cathie M Pfleger, Lauren Friedman, Roselle Vittorino, Wei Zhao, Xianjuan Qian, Lindsay Conley, Lap Ho, Giulio M Pasinetti.   

Abstract

Huntington's disease (HD) is a progressive neurodegenerative disorder associated with selective neuronal cell death. Abnormal aggregation of huntingtin protein with polyQ expansion has been shown to be causally linked to HD. Grape seed polyphenolic extract (GSPE) is a natural compound that has previously been shown to interfere with aggregations of proteins involved in neurological disorders, such as amyloid beta peptides (Aβ) and Tau protein. In this study we found that GSPE treatment significantly inhibits polyQ aggregation in phaeochromocytoma (PC)-12 cell line containing an ecdysone-inducible protein comprising the first 17 amino acid of huntingtin plus 103 glutamines fused with enhanced GFP. In vivo feasibility studies using the Q93httexon1 drosophila model of HD, we extended our in vitro evidence and found that flies fed with GSPE had a significantly improved lifespan compared to the control flies. Using the R6/2 rodent model of HD, we found that oral administration of 100 mg/kg/day GSPE (equivalent to 500mg per day in human) significantly attenuated the motor skill decay as well as extended the lifespan in the R6/2 mice relative to vehicle-control mice. Collectively, our studies strongly suggest that GSPE might be able to modulate the onset and/or progression of HD.

Entities:  

Year:  2010        PMID: 21331299      PMCID: PMC3039436          DOI: 10.2478/v10134-010-0022-y

Source DB:  PubMed          Journal:  Transl Neurosci        ISSN: 2081-6936            Impact factor:   1.757


  35 in total

1.  Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease.

Authors:  A Yamamoto; J J Lucas; R Hen
Journal:  Cell       Date:  2000-03-31       Impact factor: 41.582

2.  Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models.

Authors:  Dagmar E Ehrnhoefer; Martin Duennwald; Phoebe Markovic; Jennifer L Wacker; Sabine Engemann; Margaret Roark; Justin Legleiter; J Lawrence Marsh; Leslie M Thompson; Susan Lindquist; Paul J Muchowski; Erich E Wanker
Journal:  Hum Mol Genet       Date:  2006-08-07       Impact factor: 6.150

3.  Identification of combinatorial drug regimens for treatment of Huntington's disease using Drosophila.

Authors:  Namita Agrawal; Judit Pallos; Natalia Slepko; Barbara L Apostol; Laszlo Bodai; Ling-Wen Chang; Ann-Shyn Chiang; Leslie Michels Thompson; J Lawrence Marsh
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-16       Impact factor: 11.205

4.  Subchronic 3-month oral toxicity study of grape seed and grape skin extracts.

Authors:  S S Bentivegna; K M Whitney
Journal:  Food Chem Toxicol       Date:  2002-12       Impact factor: 6.023

5.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.

Authors:  M DiFiglia; E Sapp; K O Chase; S W Davies; G P Bates; J P Vonsattel; N Aronin
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

6.  Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals.

Authors:  J B Penney; A B Young; I Shoulson; S Starosta-Rubenstein; S R Snodgrass; J Sanchez-Ramos; M Ramos-Arroyo; F Gomez; G Penchaszadeh; J Alvir
Journal:  Mov Disord       Date:  1990       Impact factor: 10.338

Review 7.  Animal models of Huntington's disease.

Authors:  Shilpa Ramaswamy; Jodi L McBride; Jeffrey H Kordower
Journal:  ILAR J       Date:  2007

8.  Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.

Authors:  J S Steffan; L Bodai; J Pallos; M Poelman; A McCampbell; B L Apostol; A Kazantsev; E Schmidt; Y Z Zhu; M Greenwald; R Kurokawa; D E Housman; G R Jackson; J L Marsh; L M Thompson
Journal:  Nature       Date:  2001-10-18       Impact factor: 49.962

9.  Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders.

Authors:  Ivelisse Sánchez; Christian Mahlke; Junying Yuan
Journal:  Nature       Date:  2003-01-23       Impact factor: 49.962

10.  Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells.

Authors:  Wen Yang; John R Dunlap; Richard B Andrews; Ronald Wetzel
Journal:  Hum Mol Genet       Date:  2002-11-01       Impact factor: 6.150

View more
  9 in total

Review 1.  Antioxidants in Huntington's disease.

Authors:  Ashu Johri; M Flint Beal
Journal:  Biochim Biophys Acta       Date:  2011-11-23

Review 2.  Roles of resveratrol and other grape-derived polyphenols in Alzheimer's disease prevention and treatment.

Authors:  Giulio Maria Pasinetti; Jun Wang; Lap Ho; Wei Zhao; Lauren Dubner
Journal:  Biochim Biophys Acta       Date:  2014-10-12

3.  Neuroprotective and metabolic effects of resveratrol: therapeutic implications for Huntington's disease and other neurodegenerative disorders.

Authors:  Giulio Maria Pasinetti; Jun Wang; Philippe Marambaud; Mario Ferruzzi; Paul Gregor; Lindsay Alexis Knable; Lap Ho
Journal:  Exp Neurol       Date:  2011-08-30       Impact factor: 5.330

4.  Grape-seed polyphenolic extract improves the eye phenotype in a Drosophila model of tauopathy.

Authors:  Cathie M Pfleger; Jun Wang; Lauren Friedman; Roselle Vittorino; Lindsay M Conley; Lap Ho; Hayley C Fivecoat; Giulio M Pasinetti
Journal:  Int J Alzheimers Dis       Date:  2010-08-24

5.  Acetylation within the First 17 Residues of Huntingtin Exon 1 Alters Aggregation and Lipid Binding.

Authors:  Maxmore Chaibva; Sudi Jawahery; Albert W Pilkington; James R Arndt; Olivia Sarver; Stephen Valentine; Silvina Matysiak; Justin Legleiter
Journal:  Biophys J       Date:  2016-07-26       Impact factor: 4.033

6.  The Aqueous Extract of Rhizome of Gastrodia elata Protected Drosophila and PC12 Cells against Beta-Amyloid-Induced Neurotoxicity.

Authors:  Chun-Fai Ng; Chun-Hay Ko; Chi-Man Koon; Jia-Wen Xian; Ping-Chung Leung; Kwok-Pui Fung; Ho Yin Edwin Chan; Clara Bik-San Lau
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-23       Impact factor: 2.629

Review 7.  Polyphenols Beyond Barriers: A Glimpse into the Brain.

Authors:  Ines Figueira; Regina Menezes; Diana Macedo; Ines Costa; Claudia Nunes Dos Santos
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

Review 8.  Dietary Plant Polyphenols as the Potential Drugs in Neurodegenerative Diseases: Current Evidence, Advances, and Opportunities.

Authors:  Lu Yan; Min-Song Guo; Yue Zhang; Lu Yu; Jian-Ming Wu; Yong Tang; Wei Ai; Feng-Dan Zhu; Betty Yuen-Kwan Law; Qi Chen; Chong-Lin Yu; Vincent Kam-Wai Wong; Hua Li; Mao Li; Xiao-Gang Zhou; Da-Lian Qin; An-Guo Wu
Journal:  Oxid Med Cell Longev       Date:  2022-02-21       Impact factor: 6.543

Review 9.  Polyphenols: multipotent therapeutic agents in neurodegenerative diseases.

Authors:  Khushwant S Bhullar; H P Vasantha Rupasinghe
Journal:  Oxid Med Cell Longev       Date:  2013-06-06       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.